“Motif prediction of abemaciclib in a breast cancer cell line using ChIP-Seq data analysis”, Biomed. Res. Ther., vol. 9, no. 3, pp. 4971–4985, Mar. 2022, doi: 10.15419/bmrat.v9i3.732.